Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.1K Buy
166
+50
+43% +$6.1K ﹤0.01% 1503
2026
Q2
$13.2K Sell
116
-523
-82% -$51.9K ﹤0.01% 1786
2026
Q1
$60.1K Sell
639
-394
-38% -$39.3K ﹤0.01% 1249
2025
Q4
$102K Sell
1,033
-13
-1% -$1.26K ﹤0.01% 1054
2025
Q3
$88.7K Buy
1,046
+1,003
+2,333% +$79.3K ﹤0.01% 1124
2025
Q2
$2.93K Sell
43
-31
-42% -$1.96K ﹤0.01% 2080
2025
Q1
$4.48K Sell
74
-125
-63% -$8.72K ﹤0.01% 2117
2024
Q4
$13.7K Sell
199
-65
-25% -$4.63K ﹤0.01% 1725
2024
Q3
$16K Buy
264
+41
+18% +$2.61K ﹤0.01% 2035
2024
Q2
$12.7K Buy
223
+103
+86% +$5.83K ﹤0.01% 1843
2024
Q1
$6.84K Sell
120
-85
-41% -$5.1K ﹤0.01% 1555
2023
Q4
$12K Buy
205
+87
+74% +$4.92K ﹤0.01% 1518
2023
Q3
$7K Buy
118
+5
+4% +$315 ﹤0.01% 1527
2023
Q2
$8K Sell
113
-180
-61% -$12K ﹤0.01% 1379
2023
Q1
$23K Sell
293
-15
-5% -$1.17K ﹤0.01% 1321
2022
Q4
$21K Buy
308
+278
+927% +$21.3K ﹤0.01% 1275
2022
Q3
$2K Sell
30
-18
-38% -$1.33K ﹤0.01% 1793
2022
Q2
$4K Buy
+48
New +$3.64K ﹤0.01% 1503

Other funds holding INCY

Blue Trust's INCY Position: Q3 2026 in Review

Blue Trust increased its Incyte (INCY) stake by 43% in Q3 2026, buying an estimated $6.1K and bringing the position to 166 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Blue Trust first reported a position in INCY in Q2 2022 and has held it in 18 quarters since. The position peaked at $102K in Q4 2025. 796 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • Blue Trust held 166 shares of Incyte worth $20.1K as of Q3 2026.
  • Blue Trust bought 50 Incyte shares in Q3 2026, an estimated $6.1K.
  • Incyte made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1503 holding.
  • Blue Trust first reported a position in Incyte in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Incyte position peaked at $102K in Q4 2025.
  • 796 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.